Aerovate Therapeutics (AVTE) Earnings Date, Estimates & Call Transcripts → How a $0.25 cent option contract makes my top traders feel (From DTI) (Ad) Free AVTE Stock Alerts $21.77 +0.20 (+0.93%) (As of 01:43 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 20EstimatedActual EPS (Mar. 25) -$0.74 Missed By -$0.06 Consensus EPS (Mar. 25) -$0.68 Get Aerovate Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AVTE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAVTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIWhat is the 72-Hour Profit Surge?One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…Click here now to get all the details. Aerovate Therapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.78) EPSNext Year EPS Consensus Estimate: ($2.90) EPSAVTE Earnings Date and InformationAerovate Therapeutics last announced its earnings results on March 25th, 2024. The reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.68) by $0.06. Aerovate Therapeutics has generated ($2.88) earnings per share over the last year (($2.88) diluted earnings per share). Earnings for Aerovate Therapeutics are expected to decrease in the coming year, from ($2.78) to ($2.90) per share. Aerovate Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.Read More Aerovate Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/20/2024Estimated)------- 3/25/2024Q4 2023($0.68)($0.74)($0.06)($0.74)--11/13/2023Q3 2023($0.70)($0.71)($0.01)($0.71)--8/14/2023Q2 2023($0.69)($0.76)($0.07)($0.76)--5/15/2023Q1 2023($0.58)($0.67)($0.09)($0.67)--3/29/2023Q4 2022($0.58)($0.61)($0.03)($0.61)--11/14/2022Q3 2022($0.50)($0.56)($0.06)($0.56)-- Get the Latest News and Ratings for AVTE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aerovate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/15/2022Q2 2022($0.46)($0.49)($0.03)($0.49)--5/16/2022Q1 2022($0.26)($0.45)($0.19)($0.45)--3/30/2022Q4 2021-($0.07)($0.07)($0.07)--11/14/2021Q3 2021($0.26)($0.26)-($0.26)--8/15/2021Q2 2021($0.16)($23.80)($23.64)($23.80)-- Aerovate Therapeutics Earnings - Frequently Asked Questions When is Aerovate Therapeutics's earnings date? Aerovate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on AVTE's earnings history. Did Aerovate Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aerovate Therapeutics (NASDAQ:AVTE) missed the analysts' consensus estimate of ($0.68) by $0.06 with a reported earnings per share (EPS) of ($0.74). Learn more on analysts' earnings estimate vs. AVTE's actual earnings. How much profit does Aerovate Therapeutics generate each year? Aerovate Therapeutics (NASDAQ:AVTE) has a recorded net income of -$75.52 million. AVTE has generated -$2.88 earnings per share over the last four quarters. What is Aerovate Therapeutics's EPS forecast for next year? Aerovate Therapeutics's earnings are expected to decrease from ($2.78) per share to ($2.90) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Praxis Precision Medicines Earnings Savara Earnings Pharming Group Earnings Disc Medicine Earnings Cogent Biosciences Earnings SIGA Technologies Earnings Y-mAbs Therapeutics Earnings Wave Life Sciences Earnings Silence Therapeutics Earnings Lyell Immunopharma Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:AVTE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aerovate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
